Next, in a more aggressive setting, CD8+ T cells were depleted 7 days after tumor implantation, followed by treatment with the BRQ plus anti–PD-1 mAb regimen (Figure 5D and Supplemental Figure 5I). This evidence concerns the gene CD8A and neoplasm.